Drug: Capadenoson (BAY 68-4986): chronic pain clinical trials
Registry records that list "Drug: Capadenoson (BAY 68-4986)" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
3
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
3 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Capadenoson in Angina Pectoris NCT00518921 | Withdrawn | Phase 2 | Czechia, Hungary, Israel, Italy and 2 more | Bayer | 2008-03 |
| Capadenoson in Angina Pectoris NCT00518921 | Withdrawn | Phase 2 | Czechia, Hungary, Israel, Italy and 2 more | Bayer | 2008-03 |
| Capadenoson in Angina Pectoris NCT00518921 | Withdrawn | Phase 2 | Czechia, Hungary, Israel, Italy and 2 more | Bayer | 2008-03 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.